Latest Breaking News On - Sino biopharmaceutical - Page 1 : comparemela.com

Factbox-Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic

Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic

At least 11 generic versions of Novo Nordisk s popular diabetes drug Ozempic are in the final stages of clinical trials in China, as developers seek to profit from an early patent expiry of.

Sino Biopharmaceutical Limited (OTCMKTS:SBMFF) Sees Large Growth in Short Interest

Sino Biopharmaceutical Limited (OTCMKTS:SBMFF – Get Free Report) saw a significant growth in short interest in May. As of May 15th, there was short interest totalling 60,748,200 shares, a growth of 62.4% from the April 30th total of 37,411,200 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently […]

Sino Biopharmaceutical Limited (OTCMKTS:SBMFF) Short Interest Up 62.4% in May

Sino Biopharmaceutical Limited (OTCMKTS:SBMFF – Get Free Report) was the target of a large increase in short interest during the month of May. As of May 15th, there was short interest totalling 60,748,200 shares, an increase of 62.4% from the April 30th total of 37,411,200 shares. Based on an average trading volume of 0 shares, […]

Sino Biopharmaceutical Limited Announces Positive Results on Phase III Study of Benmelstobart Injection in Combination with Anlotinib Hydrochloride Capsules for First-Line Treatment of Advanced Renal Cell Carcinoma

The board of directors of Sino Biopharmaceutical Limited announced that the randomised, open, positive drug-parallel controlled, multi-centre Phase III clinical study for the first-line treatment of.